title: Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
abstract: High-throughput screening (HTS) has achieved a dominant role in drug discovery over the past 2 decades. The goal of HTS is to identify active compounds (hits) by screening large numbers of diverse chemical compounds against selected targets and/or cellular phenotypes. The HTS process consists of multiple automated steps involving compound handling, liquid transfers, and assay signal capture, all of which unavoidably contribute to systematic variation in the screening data. The challenge is to distinguish biologically active compounds from assay variability. Traditional plate controls-based and non-controls-based statistical methods have been widely used for HTS data processing and active identification by both the pharmaceutical industry and academic sectors. More recently, improved robust statistical methods have been introduced, reducing the impact of systematic row/column effects in HTS data. To apply such robust methods effectively and properly, we need to understand their necessity and functionality. Data from 6 HTS case histories are presented to illustrate that robust statistical methods may sometimes be misleading and can result in more, rather than less, false positives or false negatives. In practice, no single method is the best hit detection method for every HTS data set. However, to aid the selection of the most appropriate HTS data-processing and active identification methods, the authors developed a 3-step statistical decision methodology. Step 1 is to determine the most appropriate HTS data-processing method and establish criteria for quality control review and active identification from 3-day assay signal window and DMSO validation tests. Step 2 is to perform a multilevel statistical and graphical review of the screening data to exclude data that fall outside the quality control criteria. Step 3 is to apply the established active criterion to the quality-assured data to identify the active compounds.
authors.affiliation: University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA, USA. tos8@pitt.edu
authors.forename: Tong Ying
authors.initials: TY
authors.lastname: Shun
authors.forename: John S
authors.initials: JS
authors.lastname: Lazo
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Sharlow
authors.forename: Paul A
authors.initials: PA
authors.lastname: Johnston
mesh_terms: D001681:Biological Assay / Q000592:standards / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004121:Dimethyl Sulfoxide / Q000737:chemistry; D055808:Drug Discovery; D005189:False Positive Reactions; D057166:High-Throughput Screening Assays / Q000706:statistics & numerical data*; D011786:Quality Control; D054928:Validation Studies as Topic
chemical_list: D004121:Dimethyl Sulfoxide